Barclays Initiates Coverage On Tenet Healthcare with Overweight Rating, Announces Price Target of $113
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok has initiated coverage on Tenet Healthcare (NYSE:THC) with an Overweight rating and set a price target of $113.
March 06, 2024 | 12:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays has initiated coverage on Tenet Healthcare with an Overweight rating and a price target of $113.
The initiation of coverage by Barclays with an Overweight rating and a high price target suggests a positive outlook for Tenet Healthcare's stock. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100